Crystal structure of human dpp-iv in complex with sa-(+)-3-(aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyphenyl)- 2-methyl-5h-pyrrolo[3,4-b]pyridin-7(6h)-one

Crystal structure of human dpp-iv in complex with sa-(+)-3-(aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyphenyl)- 2-methyl-5h-pyrrolo[3,4-b]pyridin-7(6h)-one Descriptor: 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, 3-(aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyphenyl)-2-methyl-5,6-dihydro-7H-pyrrolo[3,4-b]pyridin-7-one, ... Authors: Klei, H.E. Deposit date: 2011-07-14 Release date: 2011-10-26 Last modified: 2024-11-06 Method: X-RAY DIFFRACTION (2.6 Å) Cite: 7-Oxopyrrolopyridine-derived DPP4 inhibitors-mitigation of CYP and hERG liabilities via introduction of polar functionalities in the active site. Bioorg.Med.Chem.Lett., 21, 2011

人类二肽基肽酶IV（DPP-IV）与sa-(+)-3-(氨甲基)-4-(2,4-二氯苯基)-6-(2-甲氧基苯基)-2-甲基-5H-吡咯并[3,4-b]吡啶-7(6H)-酮复合物的晶体结构
描述项：2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖、2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖-(1→4)-2-乙酰氨基-2-脱氧-β-D-吡喃葡萄糖、3-(氨甲基)-4-(2,4-二氯苯基)-6-(2-甲氧基苯基)-2-甲基-5,6-二氢-7H-吡咯并[3,4-b]吡啶-7-酮……
作者：克莱（Klei, H.E.）
入库日期：2011-07-14
发布日期：2011-10-26
最后修改日期：2024-11-06
检测方法：X射线衍射（分辨率2.6 Å）
引用文献：《7-氧代吡咯并吡啶衍生DPP-4抑制剂——通过在活性位点引入极性官能团减轻CYP及hERG脱靶风险》，Bioorg.Med.Chem.Lett., 21, 2011